Replies to post #301502 on Innovation Pharmaceuticals Inc (IPIX)

[cybermich]

Its obviously your right to be skeptical:)

But IPIX is working with a third party who did the testing!..

and the third party also wants to publish..

much different scenario:)

[MinnieM]

My expectation is that the RBL labs will know the nuances of how to submit a paper for publication to a journal. I've always suspected that Dr Menon was lacking in this area of expertise. Plus, not all papers submitted are published.

The outcome should be publication this time. From two different RBL's.







Message in reply to:

I hope it is published, but we've heard this tune before- from November 2016:
"The work has been enormous. Now it’s time for us to begin publishing in peer-reviewed journals to complement the peer-reviewed data presented at oncology conferences. We are now preparing a paper on Kevetrin and p53 for submission to relevant scientific and medical journals. This should attract more attention towards Cellceutix and benefit our shareholders."

The above quote is from ~the 20th paragraph of their 9/8/15 pr-

http://www.ipharminc.com/press-release/2016/11/16/cellceutix-announces-filing-of-its-annual-report-on-form-10-k